-
Press Release
Sandoz receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab
-
Press Release
Sandoz to launch Hyrimoz® (adalimumab-adaz) high-concentration formulation, marking Sandoz entrance into US immunology space
-
Story
Stopping free radicals at their source -
Story
Nurturing the life science ecosystem -
Story
How I built a mini-gut with next to no biology training -
Story
How to address the culture gap between academia and industry in biomedicine -
Story
Novartis and Pfizer join forces to upend oncology dogma -
Story
Neuroscientists restore cell-to-cell signaling and sociability in autism models -
Story
Eyewitness to a healer pursues new treatments for patients -
Story
COVID-19: Answering your top questions -
Story
Chan Zuckerberg Initiative friends Novartis scientist in mission to conquer disease -
Story
Challenging a young scientist to focus on patients